PERRONE, FEDERICA
 Distribuzione geografica
Continente #
AS - Asia 163
NA - Nord America 116
EU - Europa 63
SA - Sud America 21
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 367
Nazione #
US - Stati Uniti d'America 107
CN - Cina 59
SG - Singapore 56
HK - Hong Kong 23
IT - Italia 20
BR - Brasile 19
VN - Vietnam 9
CA - Canada 7
GB - Regno Unito 7
SE - Svezia 7
FI - Finlandia 5
TR - Turchia 5
IN - India 4
JP - Giappone 4
DE - Germania 3
ES - Italia 3
FR - Francia 3
PL - Polonia 3
RO - Romania 3
ZA - Sudafrica 3
AT - Austria 2
EC - Ecuador 2
LT - Lituania 2
MX - Messico 2
NL - Olanda 2
RU - Federazione Russa 2
BD - Bangladesh 1
IE - Irlanda 1
PH - Filippine 1
PK - Pakistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 367
Città #
Singapore 29
Hong Kong 23
Dallas 17
Beijing 16
Ashburn 12
Shanghai 10
Los Angeles 8
New York 8
Ho Chi Minh City 7
Boardman 6
Hefei 6
Milan 6
Montreal 5
Denver 4
São Paulo 4
Tokyo 4
Ankara 3
Helsinki 3
Turin 3
Warsaw 3
Amsterdam 2
Atlanta 2
Belo Horizonte 2
Bexley 2
Brooklyn 2
Chennai 2
Chicago 2
Guangzhou 2
Guayaquil 2
Johannesburg 2
Orem 2
Phoenix 2
Sant'Antimo 2
Seattle 2
Shenzhen 2
Xi'an 2
Amargosa 1
Araçatuba 1
Bovisio-Masciago 1
Buffalo 1
Bắc Ninh 1
Calgary 1
Campinas 1
Charleston 1
Charlotte 1
City of London 1
Coroatá 1
Cà Mau 1
Delhi 1
Dhaka 1
Dublin 1
Durban 1
Falkenstein 1
Genoa 1
Ilford 1
Kayseri 1
Kilis 1
Kunming 1
Lappeenranta 1
Lawrence 1
London 1
Manchester 1
Mexico City 1
Mumbai 1
Nuraminis 1
Nuremberg 1
Orlando 1
Passagem Franca 1
Perris 1
Pittsburgh 1
Poplar 1
Praia Grande 1
Princeton 1
Pristina 1
Quanzhou 1
Querétaro 1
Querência do Norte 1
Rome 1
Santa Clara 1
Santarém 1
Santo André 1
Sorocaba 1
Stockholm 1
São José dos Campos 1
Tarlac City 1
Tianjin 1
Toronto 1
Târgu Mureş 1
Varjota 1
Vienna 1
Vilnius 1
Wolfhagen 1
Água Boa 1
Totale 266
Nome #
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial 77
Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review” [Cancer Treatm. Rev. 114 (2023) 102511] (Cancer Treatment Reviews (2023) 114, (S0305737223000026), (10.1016/j.ctrv.2023.102511)) 60
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review 59
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 58
Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review” [Cancer Treat. Rev. 114 (2023) 102511] (Cancer Treatment Reviews (2023) 114, (S0305737223000026), (10.1016/j.ctrv.2023.102511)) 44
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171) 37
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 26
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 21
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 1
Totale 383
Categoria #
all - tutte 1.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 0 0 0 0 1 0 0 0 0
2022/202311 3 2 1 0 0 1 2 0 2 0 0 0
2023/202434 0 1 6 4 1 4 0 2 0 1 7 8
2024/2025113 12 11 3 6 4 9 22 11 11 9 4 11
2025/2026224 35 35 17 73 56 8 0 0 0 0 0 0
Totale 383